TREATMENT OF RESISTANT INFECTIONS.
D000666:Amphotericin B; D000900:Anti-Bacterial Agents; D001414:Bacitracin; D002701:Chloramphenicol; D003428:Cross Infection; D004342:Drug Hypersensitivity; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004917:Erythromycin; D007612:Kanamycin; D008712:Methicillin; D009181:Mycoses; D010406:Penicillins / Q000009:adverse effects* / Q000633:toxicity*; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D013752:Tetracycline; D014116:Toxicology; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D010406:Penicillins; D001414:Bacitracin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D000666:Amphotericin B; D013752:Tetracycline; D008712:Methicillin
AMPHOTERICIN B; ANTIBIOTICS; BACITRACIN; CHLORAMPHENICOL; CROSS INFECTION; DRUG HYPERSENSITIVITY; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; KANAMYCIN; METHICILLIN; MYCOSES; PENICILLIN; PENICILLIN TOXICOLOGY; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TETRACYCLINE; TOXICOLOGIC REPORT; VANCOMYCIN